Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuball

Showing results (201-210 of 256) with videos related to

Pageof 26
Sort By:
Blood|January 12, 2019
Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patientsGerwin Huls, Dana A Chitu, Violaine Havelange, et al.
Bone Marrow Transplantation|April 7, 2019
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019Rafael F Duarte, Myriam Labopin, Peter Bader, et al.
Nature Protocols|March 20, 2024
BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor responseMaria Alieva, Mario Barrera Román, Sam de Blank, et al.
The Journal of Clinical Investigation|June 3, 2020
γ9δ2T cell diversity and the receptor interface with tumor cellsAnna Vyborova, Dennis X Beringer, Domenico Fasci, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2018
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow TransplantationCristina Trento, Maria Ester Bernardo, Arnon Nagler, et al.
Nature Communications|May 19, 2025
Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulationThomas Kimman, Marta Cuenca, Ralph G Tieland, et al.
Blood Advances|March 4, 2026
OUTCOMES OF PATIENTS OVER 70 YEARS TREATED WITH BREXU-CEL FOR R/R MANTLE CELL LYMPHOMA: A STUDY FROM THE CTIWP OF EBMTNicole Santoro, Jarl Eduard Mooyaart, Urban Novak, et al.
Bone Marrow Transplantation|June 6, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMTGuillaume Dachy, Jarl E Mooyaart, Ludovic Gabellier, et al.
Blood|July 19, 2013
The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPARichard F Schlenk, Erdogan Taskesen, Yvette van Norden, et al.
HLA|March 11, 2026
Landscapes of HLA Mismatching in Contemporary Unrelated Haematopoietic Cell TransplantationEsteban Arrieta-Bolaños, Edouard F Bonneville, Pietro Crivello, et al.
Pageof 26

Showing results (201-210 of 256) with videos related to

Sort By:
Pageof 26
Blood|January 12, 2019
Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patientsGerwin Huls, Dana A Chitu, Violaine Havelange, et al.
Bone Marrow Transplantation|April 7, 2019
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019Rafael F Duarte, Myriam Labopin, Peter Bader, et al.
Nature Protocols|March 20, 2024
BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor responseMaria Alieva, Mario Barrera Román, Sam de Blank, et al.
The Journal of Clinical Investigation|June 3, 2020
γ9δ2T cell diversity and the receptor interface with tumor cellsAnna Vyborova, Dennis X Beringer, Domenico Fasci, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2018
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow TransplantationCristina Trento, Maria Ester Bernardo, Arnon Nagler, et al.
Nature Communications|May 19, 2025
Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulationThomas Kimman, Marta Cuenca, Ralph G Tieland, et al.
Blood Advances|March 4, 2026
OUTCOMES OF PATIENTS OVER 70 YEARS TREATED WITH BREXU-CEL FOR R/R MANTLE CELL LYMPHOMA: A STUDY FROM THE CTIWP OF EBMTNicole Santoro, Jarl Eduard Mooyaart, Urban Novak, et al.
Bone Marrow Transplantation|June 6, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMTGuillaume Dachy, Jarl E Mooyaart, Ludovic Gabellier, et al.
Blood|July 19, 2013
The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPARichard F Schlenk, Erdogan Taskesen, Yvette van Norden, et al.
HLA|March 11, 2026
Landscapes of HLA Mismatching in Contemporary Unrelated Haematopoietic Cell TransplantationEsteban Arrieta-Bolaños, Edouard F Bonneville, Pietro Crivello, et al.
Pageof 26